jvidÊÓƵ

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Liberty - Outstanding Awards (Details)

v3.20.1
Stock-Based Compensation - Liberty - Outstanding Awards (Details)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2020
USD ($)
$ / shares
shares
Additional disclosures Ìý
Total unrecognized compensation cost related to unvested equity awards | $ $ 42
Weighted average period of recognition related to unvested equity awards (in years) 1 year 10 months 24 days
Liberty SiriusXM Group Ìý
Additional disclosures Ìý
Common stock reserved for issuance 10,200,000
Liberty SiriusXM Group | Common Class A Ìý
Number of options Ìý
Outstanding at beginning of period 22,000
Granted 0
Exercised (17,000)
Outstanding at end of period 5,000
Exercisable at end of period 5,000
WAEP Ìý
Outstanding at beginning of period | $ / shares $ 22.62
Exercised | $ / shares 19.94
Outstanding at end of period | $ / shares 31.00
Exercisable at end of period | $ / shares $ 31.00
Additional disclosures Ìý
Weighted average remaining life, outstanding 8 months 12 days
Weighted average remaining life, exercisable 8 months 12 days
Liberty SiriusXM Group | Common Class B Ìý
Number of options Ìý
Granted 0
Liberty SiriusXM Group | Common Class C Ìý
Number of options Ìý
Outstanding at beginning of period 9,817,000
Granted 388,000
Exercised (36,000)
Outstanding at end of period 10,169,000
Exercisable at end of period 8,039,000
WAEP Ìý
Outstanding at beginning of period | $ / shares $ 33.90
Granted | $ / shares 39.87
Exercised | $ / shares 23.76
Outstanding at end of period | $ / shares 34.16
Exercisable at end of period | $ / shares $ 32.20
Additional disclosures Ìý
Weighted average remaining life, outstanding 3 years 6 months
Weighted average remaining life, exercisable 2 years 10 months 24 days
Aggregate intrinsic value, outstanding | $ $ 14
Aggregate intrinsic value, exercisable | $ $ 14
Formula One Group Ìý
Additional disclosures Ìý
Common stock reserved for issuance 10,000,000.0
Formula One Group | Common Class A Ìý
Number of options Ìý
Outstanding at beginning of period 1,000
Granted 0
Outstanding at end of period 1,000
Exercisable at end of period 1,000
WAEP Ìý
Outstanding at beginning of period | $ / shares $ 12.63
Outstanding at end of period | $ / shares 12.63
Exercisable at end of period | $ / shares $ 12.63
Additional disclosures Ìý
Weighted average remaining life, outstanding 2 years 8 months 12 days
Weighted average remaining life, exercisable 2 years 8 months 12 days
Formula One Group | Common Class B Ìý
Number of options Ìý
Granted 0
Formula One Group | Common Class C Ìý
Number of options Ìý
Outstanding at beginning of period 8,284,000
Granted 1,681,000
Outstanding at end of period 9,965,000
Exercisable at end of period 6,948,000
WAEP Ìý
Outstanding at beginning of period | $ / shares $ 31.16
Granted | $ / shares 28.61
Outstanding at end of period | $ / shares 30.73
Exercisable at end of period | $ / shares $ 29.89
Additional disclosures Ìý
Weighted average remaining life, outstanding 5 years
Weighted average remaining life, exercisable 4 years 4 months 24 days
Aggregate intrinsic value, outstanding | $ $ 16
Aggregate intrinsic value, exercisable | $ $ 15
Braves Group Ìý
Additional disclosures Ìý
Common stock reserved for issuance 1,400,000
Braves Group | Common Class A Ìý
Number of options Ìý
Outstanding at beginning of period 2,000
Granted 0
Outstanding at end of period 2,000
Exercisable at end of period 2,000
WAEP Ìý
Outstanding at beginning of period | $ / shares $ 11.89
Outstanding at end of period | $ / shares 11.89
Exercisable at end of period | $ / shares $ 11.89
Additional disclosures Ìý
Weighted average remaining life, outstanding 2 years 2 months 12 days
Weighted average remaining life, exercisable 2 years 2 months 12 days
Braves Group | Common Class B Ìý
Number of options Ìý
Granted 0
Braves Group | Common Class C Ìý
Number of options Ìý
Outstanding at beginning of period 1,267,000
Granted 137,000
Exercised (3,000)
Outstanding at end of period 1,401,000
Exercisable at end of period 821,000
WAEP Ìý
Outstanding at beginning of period | $ / shares $ 21.82
Granted | $ / shares 20.07
Exercised | $ / shares 11.19
Outstanding at end of period | $ / shares 21.66
Exercisable at end of period | $ / shares $ 18.82
Additional disclosures Ìý
Weighted average remaining life, outstanding 4 years 3 months 18 days
Weighted average remaining life, exercisable 2 years 9 months 18 days
Aggregate intrinsic value, outstanding | $ $ 1
Aggregate intrinsic value, exercisable | $ $ 1